Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 68.90
+0.10 (0.15%)
Jun 25, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 12.98 billion as of June 25, 2026. Its market cap has decreased by -7.21% in one year.
Market Cap
12.98B
Enterprise Value
12.79B
Revenue
8.98B
Ranking
n/a
PE Ratio
14.95
Stock Price
68.90
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 12.98B, an increase of 419.37%. That is a compound annual growth rate of 7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 12.98B | -7.30% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 406.93B |
| Caliway Biopharmaceuticals | 168.09B |
| Heron Neutron Medical | 66.86B |
| Bora Pharmaceuticals | 55.98B |
| Grape King Bio | 14.41B |
| Ever Supreme Bio Technology | 14.40B |
| EirGenix | 14.10B |
| Foresee Pharmaceuticals | 12.54B |